Anthony Della Pietra

Statistics

Publications

Citations

2.4K

H-Index

Active since

2005

Affiliations

GlaxoSmithKline (United States)(Current)

Anthony Della Pietra is an author at GlaxoSmithKline (United States) specializing in molecular oncology, epigenetic regulation in cancer, and cancer epigenetics.

Publications per year

2005–2021

Publications

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

Michael T. McCabe, Heidi M. Ott, Gopinath Ganji et al. · Nature · 2012 · 1.8K citations

Medicine, Molecular Genetics, Oncology +15

Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)

Michael T. McCabe, Alan P. Graves, Gopinath Ganji et al. · Proceedings of the National Academy of Sciences · 2012 · 485 citations · Full text

Life Sciences, Genetics, Oncology +17

The Codon 47 Polymorphism in p53 Is Functionally Significant

Xiaoxian Li, Patrick Dumont, Anthony Della Pietra et al. · Journal of Biological Chemistry · 2005 · 115 citations · Full text

Life Sciences, Genetics, Molecular Biology +13

High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells

Lorena A. Kallal, Anna Waszkiewicz, Jon‐Paul Jaworski et al. · SLAS DISCOVERY · 2021 · 10 citations · Full text

Medicine, Molecular Biology, Oncology +17

A Chemical Acetylation-Based Mass Spectrometry Platform for Histone Methylation Profiling

Francesca Zappacosta, Craig D. Wagner, Anthony Della Pietra et al. · Molecular & Cellular Proteomics · 2021 · 10 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

1–5 of 5